CLNN
Price:
$6.29
Market Cap:
$58.52M
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multip...[Read more]
Industry
Biotechnology
IPO Date
2018-10-18
Stock Exchange
NASDAQ
Ticker
CLNN
According to Clene Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 72.09M. This represents a change of 66.69% compared to the average of 43.25M of the last 4 quarters.
The mean historical Enterprise Value of Clene Inc. over the last ten years is 287.85M. The current 72.09M Enterprise Value has changed 2.40% with respect to the historical average. Over the past ten years (40 quarters), CLNN's Enterprise Value was at its highest in in the June 2020 quarter at 748.73M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
287.85M
Median
152.42M
Minimum
0
Maximum
721.72M
Discovering the peaks and valleys of Clene Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 721.72M
Minimum Annual Increase = -65.20%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 45.61M | 32.39% |
| 2023 | 34.45M | -56.22% |
| 2022 | 78.70M | -65.20% |
| 2021 | 226.14M | -60.73% |
| 2020 | 575.89M | -20.21% |
| 2019 | 721.72M | 16.36% |
| 2018 | 620.26M | Infinity% |
The current Enterprise Value of Clene Inc. (CLNN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
52.92M
5-year avg
192.16M
10-year avg
287.85M
Clene Inc.’s Enterprise Value is greater than MacroGenics, Inc. (44.18M), less than Ovid Therapeutics Inc. (96.01M), greater than Coya Therapeutics, Inc. (-29657635354.00), less than Oramed Pharmaceuticals Inc. (98.45M), greater than Whitehawk Therapeutics Inc (-24287393.00), greater than Context Therapeutics Inc. (11.29M), less than Zentalis Pharmaceuticals, Inc. (101.24M), less than Shattuck Labs, Inc. (101.48M), greater than Pliant Therapeutics, Inc. (16.18M), less than Connect Biopharma Holdings Limited (102.22M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 44.18M | $87.30M | |
| 96.01M | $115.21M | |
| -29657635354.00 | $99.69M | |
| 98.45M | $113.33M | |
| -24287393.00 | $120.65M | |
| 11.29M | $94.64M | |
| 101.24M | $101.15M | |
| 101.48M | $142.27M | |
| 16.18M | $80.50M | |
| 102.22M | $141.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Clene Inc.'s Enterprise Value?
What is the highest Enterprise Value for Clene Inc. (CLNN)?
What is the 3-year average Enterprise Value for Clene Inc. (CLNN)?
What is the 5-year average Enterprise Value for Clene Inc. (CLNN)?
How does the current Enterprise Value for Clene Inc. (CLNN) compare to its historical average?